echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > FDA approves donepezil transdermal patch for Alzheimer's disease

    FDA approves donepezil transdermal patch for Alzheimer's disease

    • Last Update: 2022-04-21
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    FDA Approved: Yes (First approved March 11, 2022)
    Brand name: Adlarity
    Generic name: donepezil
    Dosage form: Transdermal System
    Company: Corium, Inc.



    FDA

    On March 14, 2022, a Boston-based company called Corium, Inc announced that the FDA has approved its Adlarity (donepezil transdermal system, donepezil transdermal patch) for the treatment of patients with mild, moderate or severe Alzheimer's disease.


    patients with heimer's disease


    Adlarity (donepezil transdermal system, donepezil transdermal patch) Adlarity (donepezil transdermal system, donepezil transdermal patch) patients with mild, moderate or severe Alzheimer's disease patients with mild, moderate or severe Alzheimer's disease FDA Accepts NDA for ADLARITY (Donepezil Transdermal System) to Treat Alzheimer's Disease

    Donepezil transdermal patch

    Donepezil transdermal patch (Adlarity) is a mild patch containing the active ingredient donepezil administered once a week, which can be applied continuously for 7 days to maintain a stable dose of the drug with stable adhesion
    .


    This mode of administration avoids the inconvenience of daily dosing in patients with memory deficits


    Donepezil transdermal patch (Adlarity)

    Donepezil, currently the most prescribed drug for Alzheimer's disease, is the active ingredient in the oral drug Aricept®
    .


    Donepezil is a hexahydropyridine oxide, a second-generation reversible central acetylcholine inhibitor


    Digestion Digestion

    Key takeaways:

    Key takeaways:
    • Alzheimer's disease is a progressive and irreversible brain disease that involves changes in brain tissue, including abnormal accumulation of proteins and loss of neuronal function
      .


      It is characterized by loss of memory, reasoning, and thinking abilities


      TM TM References: https:// Leave a comment here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.